½ðÄê»á

À´Ô´£º¼Ó°àͼƬ£¬×÷Õߣº £¬£º

ÚÀѽ£¬ÎÒ¸úÄã½²°¡£¬×î½üÔÛ·ï¸ÚÕòÕâÁµ°®Ð¡Ïï×Ó£¬ÄÇ¿ÉÊÇÔôÀ­»ð£¡ÄãÖªµÀ²»£¬ÄêÇáÈ˰¡£¬ÕûÌì³ÉË«³É¶Ô¶ùµØÍùÄǶù×ê¡£¾ÍÁ¬ÀÏЩËêÊýµÄÒÌÂè´óÊ壬ҲÔôÀ­°®È¥³òÒ»ÑÛ¡£ÎÒѰ˼°É£¬ÕâÏï×ÓÀïÍ·Ëü¾¿¾¹ÓÐÉ¶ÍæÒâ¶ùÄÜÕâô´ø¾¢¶ùÄØ£¿½ñÌìÔÛ¾ÍßëÒ»ßëÕâʶù¡£

Áµ°®Ð¡Ïï×ӵġ°´«Ëµ¡±£¬Ìý×ÅͦÐþºõ

ÄãÒªÎÊÎÒ£¬ÕâÁµ°®Ð¡Ïï×ÓÕ¦¾Í»ðÁËÄØ£¿ÄǵôÓËüµÄÃû×Ö˵Æð¡£Ìý˵°¡£¬ÕâµØ·½ÔçЩÄêÍ·¶ù£¬ÊÇÕòÉÏÒ»¸öÀÏľ½³¸ø×Ô¼Ò¹ëÅ®¸ÇµÄ¼Þ×±·¿£¬ØÊºó¹ëÅ®³ö¼ÞÁË£¬ÕâÏï×Ӿͱ»½Ð³ÉÁË¡°Áµ°®Ïï×Ó¡±¡£

Ïà¹ØÍ¼Æ¬

ØÊºó°É£¬²»ÖªµÀÕ¦µÄ£¬ÕâµØ·½¾Í´«³öÁË¡°À´Õâ¶ùÄÜÕÒµ½Õæ°®¡±µÄ˵·¨¡£ÓÈÆäÊÇÏï×ÓÀïÄÇ¿ÃÀÏ»±Ê÷£¬·»¼äÌý˵˵£¬Á©ÈËÒªÊǶÔ×ÅÊ÷ÐíÔ¸°¡£¬Çé¸Ð¾ÍÄܸúÕ³¶¹°üËÆµÄ£¬ð¤ð¤ºýºýÒ»±²×Ó¡£ÄãËÃ÷ÈÕâ¶àÐþºõ£¿µ«ÎÒ¸úÄã½²°¡£¬Õâʶù»¹ÕæÓв»ÉÙÈËÐÅ¡£

Ïï×ÓÀïµÄ¡°ÃŵÀ¶ù¡±£¬²»¶®»¹ÕæÕû²»Ã÷°×

Æäʵ°É£¬ÕâÁµ°®Ð¡Ïï×Ó£¬ÍâòÉÏ¿´¾ÍÊǸöСºúͬ£¬Ã»É¶Ï¡ÆæµÄ¡£µ«Äã×Ðϸ¿´£¬ºÙ£¬ÀïÍ·»¹ÕæÓеãÒâ˼¡£

ÏÈ˵Ïï×ÓÁ½±ßµÄǽ£¬Äã×¢Òâ¹ýû£¿ÄÇǽÉÏÈ«ÊÇЩÀÏÕÕÆ¬£¬É¶ÄêÇáʱºòµÄ»éÀñÕÕ¡¢È«¼Ò¸£É¶µÄ£¬ÉõÖÁÁíÓÐÈËÊÖдµÄÇéÊéÌùÄǶùÄØ£¡Ìý˵£¬ÕâЩ¶¼ÊÇËÄÖܾÓÃñ×Ô¼ºÄÃÀ´µÄ£¬Ô­Ö­Ô­Î¶£¬Ôô½ÓµØÆø¶ù¡£

ÔÙÓоÍÊÇÏï×ÓÉî´¦µÄÄǼ¸¼ÒСµê¡£Ò»¸öÂôÌǺù«µÄÀÏ´óÄ¸úÎÒ˵ËýÕâÌǺù«ÊÇ×Ô¼º°¾µÄÌǽ¬£¬ËáÌð¿É¿Ú£¬³ÔÁËÄÜÈÃÈËÐÄÇéÔôºÃ¡£ÎÒ»¹Åöµ½Ò»¼ÒÂô¶¨ÖÆÊÖ¹¤ÊÎÆ·µÄСÆÌ×Ó£¬µêÀϰå˵£¬ÇéÂÂÀ´Õâ¶ù£¬Âò¸öÊÖ´®¶ù£¬¾Íµ±¸ö¼ÍÄî¡£Õâ²»£¬±ð¿´Ïï×Ó²»´ó£¬ÀïÍ·µÄÃŵÀ¶ù¿É²»ÉÙ¡£

ÇÄÃþ¸æËßÄ㣺Ïï×ÓÀïÓмҲ»ÆðÑÛµÄС̯£¬ÂôµÄÊÇ¡°Ô¸ÍûËø¡±¡£Ìý˵°¡£¬Äã¸ú¹¤¾ßÒ»ÈËдһ¾ä»°ËøÉÏÈ¥£¬Çé¸Ð¾Í¸úÕâËøËÆµÄ£¬ËÀ¿Ûס²»É¢¡£É¶ÑùµÄ»°¶¼ÐУ¬µ«Òªº¦ÊǵÿÒÇС£ÄãҪû¹¤¾ß£¬Ò²ÐУ¬ËøÒ»¸ö¡°Ô¸Íû¡±£¬ËµÎ´±ØÄÄÌìÕæÁéÁËÄØ£¡

Áµ°®Ð¡Ïï×ӵġ°ÕýÈ··­¿ª·½·¨¡±£¬ÎÒÓо­Ñé

Ïà¹ØÍ¼Æ¬

ÕÕÎÒ˵°¡£¬ÄãÒªÀ´ÕâÏï×ÓÍæ£¬ÄǾ͵ÃÂýÓÆÓÆµØÁï´ï£¬²»¿É¼±¡£×îºÃÄØ£¬´øÉÏÒ»¸öÄÜßëྵÄÅóÓÑ»òÕß¹¤¾ß£¬±ß×ß±ßÁÄ¡£Òª²»È»¾Í¸úÎÒËÆµÄ£¬ÉÏ»ØÎÒÒ»¸öÈËÈ¥£¬ÕûµÃÀÏûÒâ˼ÁË¡£

ÁíÓа¡£¬Ïï×ÓÀïµÄÄÇ¿ÃÀÏ»±Ê÷£¬Äã±ð¹â¿´£¬µÃÃþÒ»Ãþ¡£¾Ý˵Ãþ×ÅÊ÷¸É£¬Ïë×ÅÐÄÊ£¬¿ÉÄÜ»áÓС°Áé¸Ð¡±¡£ÎÒÄêÇáÄÇ»á¶ù£¬¸úÎÒϱ¸¾¶ù¾ÍÊÇÃþÁË»±Ê÷£¬È»ºó¾ö¶¨½á»éµÄ£¡Äã˵Çɲ»ÇÉ£¿

Ïà¹ØÍ¼Æ¬

×îºóßëÒ»¾ä£ºÄãÎÊÎÒÖµ²»ÖµµÃÈ¥£¿

Öµ²»ÖµµÃ°¡£¿Öµ£¡µ«ÄãÒª±¼×Åɶ´«ÆæÁµ°®¹ÊÊÂÈ¥£¬ÄǾͱðÌ«ÈÏÕæ£¬Í¼¸öÈÈÄÖ¾ÍÐС£ÕâµØ·½°É£¬¸ü¶àÊÇÈÃÈËͼ¸öÀֺǣ¬ÁôµãС¼ÍÄîɶµÄ¡£

ËùÒÔ°¡£¬ÄÄÌìûʶù£¬½ÐÉÏÅóÓÑ»òÕß¹¤¾ßÈ¥Áï´ïÁï´ï£¬³ÔµãÌǺù«£¬¿´¿´ÇéÊ飬¸ú»±Ê÷ßëßëྣ¬ÕâÈÕ×Ó²»¾ÍÓÐ×ÌζÁËÂ


±êÇ©£ºÁµ°®Ð¡Ïï×Ó¡¢·ï¸ÚÕò¡¢¶«±±ÌØÉ«¡¢Áµ°®´«Ëµ¡¢»±Ê÷Ô¸Íû

¡¶Ô¼¼¦Å®»õµ½¸¶¿î¡·

4. Zierath, J. R.?et al.?Translating metabolic and cardiovascular research into effective treatments: What's next??Cell187, 3880-3884 (2024).

¡¶ÑγÇÕÐÉ̳¡Ïï×Ó¡·

ÐÅÓýôËõ£ºÔÚÒøÐÐ·ç¿ØÊÕ½ôµÄÅä¾°Ï£¬ÐÅÓÃÖ¤¿ªÁ¢ÄÑ¡¢ÈÚ×ʱ¾Ç®¸ßÆó£¬ÈκÎÒ»¸ö»·½ÚµÄ×ʽð¶ÏÁѶ¼¿ÉÄÜÒý·¢Á¬ËøÎ¥Ô¼¡£

¡¶ÄÄÓÐѧÉúЧÀÍ¡·

Õâ¼Ò»ª¶û½Ö¹«Ë¾Ô¤¼Æ³¬´ó¹æÄ£ÔÆÐ§ÀÍÉ̵ÄͶ×ʽ«¼á³ÖÇ¿¾¢,Êг¡¹²Ê¶Ä¿Ç°Ö¸Ïò2026Äê×ʱ¾Ö§³öΪ6,670ÒÚÃÀÔª,ͬ±ÈÔö³¤62%¡£¾¡¹ÜÈç´Ë,ÓÉRyan HammondÁìµ¼µÄÆÊÎöʦÍŶÓÔ¤¼ÆÔö³¤ËٶȽ«ÔÚ½ñÄêÍíЩʱºòµÖ´ï·åÖµ,²¢¾¯¸æ³Æ,Èç¹ûÖ§³öÊÆÍ·½µÎÂ,AI»ù´¡ÉèÊ©ÁìÓòµÄ²¿·Ö¹«Ë¾¿ÉÄÜÃæÁÙѹÁ¦¡£

ÍøÕ¾µØÍ¼